Vertex Pharmaceuticals Inc (VRTX)
Market Closed
10 Jan, 20:00
$
409. 56
-2.55
-0.62%
Pre Market
$
-4.56 -1.11% 405. 00
101.7B Market Cap
- P/E Ratio
0% Div Yield
1,687,900 Volume
0 Eps
$ 412.11
Previous Close Day Range
405.17 413.52
Year Range
377.85 519.88
Earnings results expected in 21 days
Summary
VRTX closed Friday lower at $409.56, a decrease of 0.62% from Thursday's close, completing a monthly increase of 1.59% or $6.42. Over the past 12 months, VRTX stock gained 1.59%.
VRTX is not paying dividends to its shareholders.
The last earnings report, released on Nov 04, 2024, exceeded the consensus estimates by 0.24%. On average, the company has fell short of earnings expectations by -6.57%, based on the last three reports. The next scheduled earnings report is due on Feb 03, 2025.
The stock of the company had never split.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
Want to track VRTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
VRTX Chart
FAQ
What Is the Vertex Pharmaceuticals Inc(VRTX) Stock Price Today?
The VRTX stock price today is $409.56.
What Stock Exchange Does Vertex Pharmaceuticals Inc Trade On?
Vertex Pharmaceuticals Inc is listed and trades on the NASDAQ (NGS).
What Is the Stock Symbol for Vertex Pharmaceuticals Inc?
The stock symbol for Vertex Pharmaceuticals Inc is "VRTX".
Does Vertex Pharmaceuticals Inc Pay Dividends? What's The Current Dividend Yield?
VRTX is not paying dividends to its shareholders.
What Is the Vertex Pharmaceuticals Inc Market Cap?
As of today, Vertex Pharmaceuticals Inc market cap is 101.7B.
What is Vertex Pharmaceuticals Inc Earnings Per Share?
The Vertex Pharmaceuticals Inc EPS is 0.
What Is the Next Vertex Pharmaceuticals Inc Earnings Date?
Vertex Pharmaceuticals Inc will release its next earnings report on Feb 03, 2025.
Did Vertex Pharmaceuticals Inc had any splits?
No, Vertex Pharmaceuticals Inc has never had a stock split.
Vertex Pharmaceuticals Inc Profile
| Other Industry | Other Sector | - CEO | NASDAQ (NGS) Exchange | US92532F1003 ISIN |
| DE Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
There is no Profile data available for VX1.BE.
Contact Information
2025 © Marketlog. All Rights Reserved.
